Summary: The rise of AI in healthcare has led to calls for regulation to ensure its responsible and safe use. While efforts have been made to draft legislation in both the EU and the US, there are concerns about the regulatory process and the potential impact on the industry. Various associations and organizations are forming to address these concerns and propose solutions. The EU AI Act is expected to come into effect in 2026, but there are debates about its provisions and the preference for self-regulation in countries like France and Germany. The upcoming European elections may also influence the implementation of AI regulation. The Global Agency for Responsible AI in Health aims to advocate for responsible use of AI in healthcare and create a comprehensive repository of validated AI technologies. The industry will discuss these issues further at HIMSS24 Europe.
Amidst the excitement surrounding the rise of AI in healthcare, there is a growing consensus that regulation is necessary to ensure its responsible and safe use. Efforts have been made to draft legislation in both the EU and the US, but there are concerns about the regulatory process and its potential impact on the industry.
In the US, the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence has mandated the establishment of an AI Task Force within the Health and Human Services (HHS) department. This task force is responsible for developing a regulatory action plan for AI-enabled technologies in healthcare by 2024.
Meanwhile, in the EU, the AI Act is expected to be finalized in 2024 and come into effect by 2026. However, there is criticism regarding the transparency and oversight of the negotiation process. Some experts argue that regulations should only be applied at the application level, allowing for scientific freedom and preventing consolidation of power in the hands of tech corporations.
Furthermore, there are debates within the EU about the preference for self-regulation, particularly in countries like France and Germany. This has raised concerns about the harmonization of regulations and the potential for poor policies that could undermine efforts to ensure responsible use of AI in healthcare.
The upcoming European elections may also influence the implementation of AI regulation, with potential shifts in political power affecting the act’s provisions. Harmonization is critical to ensure the safe and efficient use of AI in healthcare, and industry leaders stress the importance of balancing the risks and benefits of AI technology.
To address these concerns, organizations like the Global Agency for Responsible AI in Health are advocating for the use of principles similar to those used in medicines approval and health technology assessment for AI in healthcare. They aim to create a comprehensive repository of validated AI technologies, providing a global showcase for responsible and effective AI solutions.
Further discussions on these topics will take place at HIMSS24 Europe, which will feature a dedicated track on AI in healthcare. These discussions will help shape the future of AI regulation and its impact on the healthcare industry.
The source of the article is from the blog girabetim.com.br